A. Vasilyev

Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study

A. M. Degtyarev, R. Zukov, A. Vasilevskaya, 2022, Journal of Modern Oncology.

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia

E. Imyanitov, R. Zukov, A. Iyevleva, 2021 .

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.

J. Machiels, T. Seiwert, A. Psyrri, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.